Abiopharma

🔍 Gomide de Faria Mariano (Executive)

Company: VTEX (NYSE: VTEX)

Report Date: 2026-03-31

Detailed Transactions and Holdings:

• Sold 4,808 shares of Class A Common Stock at $4.01 per share (Direct)
  Date: 2026-03-31 | Code: S | equity_swap_involved: false | shares_owned_after: 41,241.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: H | shares_owned_after: 579,813.00
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-03-31 | Code: H | nature_of_ownership: By Class M | shares_owned_after: 14,100.00

Footnotes:

• F1: Represents sales effected pursuant to a Rule 10b5-1 Trading Plan adopted by the Reporting Person on October 11, 2025.
• F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from USD $4.00 to USD $4.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
• REMARKS: Due to the Issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Securities Exchange Act of 1934 (the "Act"), the reporting person's transactions in the Issuer's equity securities are exempt from Sections 16(b) and 16(c) of the Act.